We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
76
American Express
AXP
$234B
$221M 0.23%
1,180,530
-16,854
-1% -$2.71M
SBUX icon
77
Starbucks
SBUX
$120B
$220M 0.23%
2,292,622
-12,568
-0.5% -$1.22M
TJX icon
78
TJX Companies
TJX
$174B
$220M 0.23%
2,342,782
-20,346
-0.9% -$1.83M
RTX icon
79
RTX Corp
RTX
$294B
$219M 0.23%
2,606,573
-45,090
-2% -$3.57M
MDT icon
80
Medtronic
MDT
$110B
$219M 0.23%
2,659,096
-22,411
-0.8% -$1.71M
UPS icon
81
United Parcel Service
UPS
$92.7B
$217M 0.23%
1,377,055
-12,524
-0.9% -$1.89M
CVS icon
82
CVS Health
CVS
$133B
$215M 0.23%
2,722,021
+23,877
+0.9% +$1.7M
LRCX icon
83
Lam Research
LRCX
$398B
$209M 0.22%
2,668,660
-71,100
-3% -$4.85M
MDLZ icon
84
Mondelez International
MDLZ
$79.2B
$208M 0.22%
2,871,585
+50,781
+2% +$3.48M
SCHW
85
Charles Schwab
SCHW
$185B
$208M 0.22%
3,020,971
-44,886
-1% -$2.59M
ZTS icon
86
Zoetis
ZTS
$31.9B
$205M 0.21%
1,038,162
-11,509
-1% -$2.04M
SYK icon
87
Stryker
SYK
$129B
$200M 0.21%
668,028
-9,458
-1% -$2.65M
ADP icon
88
Automatic Data Processing
ADP
$108B
$197M 0.21%
846,416
-3,790
-0.4% -$883K
MRSH
89
Marsh
MRSH
$91.4B
$196M 0.21%
1,035,281
+8,296
+0.8% +$1.6M
IWB icon
90
iShares Russell 1000 ETF
IWB
$49.9B
$195M 0.2%
745,124
+407,812
+121% +$99.9M
ADI icon
91
Analog Devices
ADI
$185B
$194M 0.2%
975,074
-15,488
-2% -$2.77M
BMY icon
92
Bristol-Myers Squibb
BMY
$135B
$194M 0.2%
3,771,690
-172,245
-4% -$9.04M
C icon
93
Citigroup
C
$230B
$190M 0.2%
3,688,800
-106,400
-3% -$4.71M
CI icon
94
Cigna
CI
$72.4B
$188M 0.2%
629,398
-21,116
-3% -$6.17M
VRTX icon
95
Vertex Pharmaceuticals
VRTX
$121B
$187M 0.2%
458,488
-5,263
-1% -$1.94M
LMT icon
96
Lockheed Martin
LMT
$136B
$186M 0.19%
409,527
-12,238
-3% -$5.42M
PGR icon
97
Progressive
PGR
$123B
$185M 0.19%
1,159,317
-9,131
-0.8% -$1.43M
ETN icon
98
Eaton
ETN
$173B
$181M 0.19%
750,593
-2,664
-0.4% -$588K
MU icon
99
Micron Technology
MU
$1.01T
$173M 0.18%
2,032,862
-56,448
-3% -$4.19M
BSX icon
100
Boston Scientific
BSX
$71.1B
$171M 0.18%
2,956,286
+8,634
+0.3% +$461K

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.